This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Guardian Pharmacy Services, Inc. Class A (GRDN) Gets a Buy from Oppenheimer

Tipranks - Tipranks - Mon Mar 23, 8:06AM CDT

Oppenheimer analyst Michael Wiederhorn maintained a Buy rating on Guardian Pharmacy Services, Inc. Class A on March 20. The company’s shares closed last Friday at $35.62.

Claim 30% Off TipRanks Premium

According to TipRanks, Wiederhorn is a 5-star analyst with an average return of 9.2% and a 57.65% success rate. Wiederhorn covers the Healthcare sector, focusing on stocks such as Pennant Group, Guardian Pharmacy Services, Inc. Class A, and Chemed.

The word on The Street in general, suggests a Strong Buy analyst consensus rating for Guardian Pharmacy Services, Inc. Class A with a $37.00 average price target, implying a 3.87% upside from current levels. In a report released on March 12, Truist Financial also reiterated a Buy rating on the stock with a $38.00 price target.

See the top stocks recommended by analysts >>

Based on Guardian Pharmacy Services, Inc. Class A’s latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of $397.62 million and a net profit of $20.92 million. In comparison, last year the company earned a revenue of $338.57 million and had a net profit of $11.94 million

Read More on GRDN:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).